| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |